This is great. identified 89% of patients with oesophageal adenocarcinoma and 92% of patients without the disease in studies of
300 patients across two patient cohorts. a simple blood testing will do.
- Forums
- ASX - By Stock
- Ann: Study validates biomarkers for oesophageal cancer blood test
This is great. identified 89% of patients with oesophageal...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
-0.040(3.88%) |
Mkt cap ! $132.2M |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 99.0¢ | $357.0K | 353.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2446 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2446 | 0.990 |
2 | 9800 | 0.985 |
2 | 10511 | 0.980 |
2 | 7352 | 0.975 |
6 | 45477 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 2000 | 1 |
1.020 | 4990 | 1 |
1.030 | 72045 | 1 |
1.060 | 2508 | 1 |
1.070 | 7000 | 1 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
99.5¢ |
  |
Change
-0.040 ( 3.40 %) |
|||
Open | High | Low | Volume | ||
$1.03 | $1.03 | 99.0¢ | 24125 | ||
Last updated 15.58pm 21/05/2024 ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online